Successful rituximab treatment of granulomatosis with polyangiitis with cranial neuropathies | Inflammation and Regeneration | Full Text
Clinical Response and Pattern of B cell Suppression with Single Low Dose Rituximab in Nephrology | American Society of Nephrology
Rituximab (RTX) stimulation induces SHP-1 recruitment to CD16 z chain.... | Download Scientific Diagram
Level of rituximab (RTX) and B cells after initiation of RTX therapy in... | Download Scientific Diagram
Hypersialylation characterizes CLL cells resistant to rituximab (RTX)... | Download Scientific Diagram
A New Schedule of CHOP/Rituximab Plus Granulocyte-Macrophage Colony-Stimulating Factor Is an Effective Rescue for Patients with Aggressive Lymphoma Failing Autologous Stem Cell Transplantation - Biology of Blood and Marrow Transplantation
Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis with Severe Kidney Disease | American Society of Nephrology
Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis - The Journal of Allergy and Clinical Immunology: In Practice
Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo | Leukemia
Rituximab (RTX)-induces in vitro complement-dependent cytotoxicity... | Download Scientific Diagram
Internalization of rituximab (RTX) to a highly variable extent,... | Download Scientific Diagram
Current perspective on rituximab in rheumatic diseases | DDDT
In vitro and in vivo treatment with rituximab (RTX) leads to CD20KO... | Download Scientific Diagram
Reconstitution of B cells after one cycle of rituximab (RTX) with... | Download Scientific Diagram
PV | RITUXAN® (rituximab) Dosing & Infusion Resources
Rituximab Therapy for Severe Refractory Chronic Henoch-Schönlein Purpura - The Journal of Pediatrics
Rituximab Prolongs the Time to Relapse in Patients with Immune Thrombotic Thrombocytopenic Purpura: Analysis of Off-Label Use in Japan - ISTH Congress Abstracts
Del(17p) influences the pharmacokinetics of rituximab (RTX). Del(17p)... | Download Scientific Diagram
How does ocrelizumab differ from rituximab? - Quora
Immunosuppressive therapy with rituximab in common variable immunodeficiency | Clinical and Molecular Allergy | Full Text
Activatory and Inhibitory Fcγ Receptors Augment Rituximab-mediated Internalization of CD20 Independent of Signaling via the Cytoplasmic Domain* - Journal of Biological Chemistry
Ex-Vivo Perfusion Mediated Delivery of Rituximab to Clear Latent Epstein-Barr Virus - ATC Abstracts
